ClinicalTrials.gov
public full text
Public Domain
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
colorectal-cancer-crcgastric-cancernon-small-cell-lung-cancer-nsclcsolid-tumorsquamous-cell-carcinoma-of-head-and-neck
This is a first in human, multi-center, open-label, dosage escalation study to determine the recommended dose range of TH9619 in subjects with advanced cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PRO1107 in Patients With Advanced Solid Tumors#852344
- A Study of ICP-192 in Patients With Advanced Solid Tumors#1152413
- A Phase 1 Study of ARQ 197 in Patients With Solid Tumors#917119
- Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion#848461
- A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors#895711
Record · ID 1029817
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive